 | • レポートコード：D005-10037 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、麻疹ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。麻疹ワクチンの種類別市場規模（不活化ワクチン、弱毒ワクチン）、用途別市場規模（病院、科学研究、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Biovac、McKesson Medical ・地域別グローバル市場分析 2015年-2020年 ・麻疹ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・麻疹ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・麻疹ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・麻疹ワクチンの南米市場（ブラジル、アルゼンチン） ・麻疹ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：不活化ワクチン、弱毒ワクチン ・用途別分析：病院、科学研究、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Measle Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Measle Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Measle Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Measle Vaccine market has been segmented into
Inactivated Vaccine
Attenuated Vaccine
By Application, Measle Vaccine has been segmented into:
Hospital
Scientific Research
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Measle Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Measle Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Measle Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Measle Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Measle Vaccine Market Share Analysis
Measle Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Measle Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Measle Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Measle Vaccine are:
GSK
Biovac
McKesson Medical
Among other players domestic and global, Measle Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measle Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Measle Vaccine, with price, sales, revenue and global market share of Measle Vaccine in 2018 and 2019.
Chapter 3, the Measle Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measle Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Measle Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Measle Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Measle Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Measle Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Measle Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Overview of Global Measle Vaccine Market
1.4.1 Global Measle Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Measle Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biovac
2.2.1 Biovac Details
2.2.2 Biovac Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biovac SWOT Analysis
2.2.4 Biovac Product and Services
2.2.5 Biovac Measle Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 McKesson Medical
2.3.1 McKesson Medical Details
2.3.2 McKesson Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 McKesson Medical SWOT Analysis
2.3.4 McKesson Medical Product and Services
2.3.5 McKesson Medical Measle Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Measle Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Measle Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Measle Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Measle Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Measle Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Measle Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Measle Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Measle Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Measle Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Measle Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Measle Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Measle Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Measle Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Measle Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Measle Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Measle Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Measle Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Measle Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Measle Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Measle Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Measle Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Measle Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Measle Vaccine Sales and Growth Rate (2015-2020)
6.4 France Measle Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Measle Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Measle Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Measle Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Measle Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Measle Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Measle Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Measle Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Measle Vaccine Sales and Growth Rate (2015-2020)
7.5 India Measle Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Measle Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Measle Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Measle Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Measle Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Measle Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Measle Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Measle Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Measle Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Measle Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Measle Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Measle Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Measle Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Measle Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Measle Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Measle Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Measle Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Measle Vaccine Price by Type (2015-2020)
11 Global Measle Vaccine Market Segment by Application
11.1 Global Measle Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Measle Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Measle Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Measle Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Measle Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Measle Vaccine Market Forecast (2021-2025)
12.2.2 Europe Measle Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Measle Vaccine Market Forecast (2021-2025)
12.2.4 South America Measle Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Measle Vaccine Market Forecast (2021-2025)
12.3 Measle Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Measle Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Measle Vaccine Market Share Forecast by Type (2021-2025)
12.4 Measle Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Measle Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Measle Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Measle Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Measle Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Measle Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Measle Vaccine Major Business
Table 9. GSK Measle Vaccine Total Revenue (USD Million) (2018-2019)
Table 10. GSK SWOT Analysis
Table 11. GSK Measle Vaccine Product and Services
Table 12. GSK Measle Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Biovac Basic Information, Manufacturing Base and Competitors
Table 14. Biovac Measle Vaccine Major Business
Table 15. Biovac Measle Vaccine Total Revenue (USD Million) (2018-2019)
Table 16. Biovac SWOT Analysis
Table 17. Biovac Measle Vaccine Product and Services
Table 18. Biovac Measle Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. McKesson Medical Basic Information, Manufacturing Base and Competitors
Table 20. McKesson Medical Measle Vaccine Major Business
Table 21. McKesson Medical Measle Vaccine Total Revenue (USD Million) (2018-2019)
Table 22. McKesson Medical SWOT Analysis
Table 23. McKesson Medical Measle Vaccine Product and Services
Table 24. McKesson Medical Measle Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Global Measle Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 26. Global Measle Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 27. Global Measle Vaccine Sales by Regions (2015-2020) (K Units)
Table 28. Global Measle Vaccine Sales Market Share by Regions (2015-2020)
Table 29. Global Measle Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 30. North America Measle Vaccine Sales by Countries (2015-2020) (K Units)
Table 31. North America Measle Vaccine Sales Market Share by Countries (2015-2020)
Table 32. North America Measle Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 33. North America Measle Vaccine Revenue Market Share by Countries (2015-2020)
Table 34. Europe Measle Vaccine Sales by Countries (2015-2020) (K Units)
Table 35. Europe Measle Vaccine Sales Market Share by Countries (2015-2020)
Table 36. Europe Measle Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 37. Asia-Pacific Measle Vaccine Sales by Regions (2015-2020) (K Units)
Table 38. Asia-Pacific Measle Vaccine Sales Market Share by Regions (2015-2020)
Table 39. Asia-Pacific Measle Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 40. South America Measle Vaccine Sales by Countries (2015-2020) (K Units)
Table 41. South America Measle Vaccine Sales Market Share by Countries (2015-2020)
Table 42. South America Measle Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 43. South America Measle Vaccine Revenue Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Measle Vaccine Sales by Countries (2015-2020) (K Units)
Table 45. Middle East & Africa Measle Vaccine Sales Market Share by Countries (2015-2020)
Table 46. Middle East & Africa Measle Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 47. Middle East & Africa Measle Vaccine Revenue Market Share by Countries (2015-2020)
Table 48. Global Measle Vaccine Sales by Type (2015-2020) (K Units)
Table 49. Global Measle Vaccine Sales Share by Type (2015-2020)
Table 50. Global Measle Vaccine Revenue by Type (2015-2020) (USD Million)
Table 51. Global Measle Vaccine Revenue Share by Type (2015-2020)
Table 52. Global Measle Vaccine Sales by Application (2015-2020) (K Units)
Table 53. Global Measle Vaccine Sales Share by Application (2015-2020)
Table 54. Global Measle Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 55. Global Measle Vaccine Market Share Forecast by Regions (2021-2025)
Table 56. Global Measle Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 57. Global Measle Vaccine Market Share Forecast by Type (2021-2025)
Table 58. Global Measle Vaccine Sales Forecast by Application (2021-2025)
Table 59. Global Measle Vaccine Market Share Forecast by Application (2021-2025)
Table 60. Direct Channel Pros & Cons
Table 61. Indirect Channel Pros & Cons
Table 62. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Measle Vaccine Picture
Figure 2. Global Sales Market Share of Measle Vaccine by Type in 2019
Figure 3. Inactivated Vaccine Picture
Figure 4. Attenuated Vaccine Picture
Figure 5. Measle Vaccine Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Scientific Research Picture
Figure 8. Others Picture
Figure 9. Global Measle Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Measle Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Measle Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Measle Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Measle Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Measle Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Measle Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Measle Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Measle Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Measle Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Measle Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Measle Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Measle Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Measle Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Measle Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Measle Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Measle Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Measle Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Measle Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Measle Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Measle Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Measle Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Measle Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Measle Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Measle Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Measle Vaccine Revenue Market Share by Regions 2019
Figure 62. China Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Measle Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Measle Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Measle Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Measle Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Measle Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Measle Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Measle Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Measle Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Measle Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Measle Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Measle Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Measle Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Measle Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Measle Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Measle Vaccine Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
ライム病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyme Disease Vaccine mar…- 不活化ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Inactivated Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 6752.5 million by 2025, from USD 5952.8 million in 2019. The Inactivated Vacc…
- ヒト用予防ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Prophylactic Human Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prophylactic Human…
- 弱毒生ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Live Attenuated Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Live Attenuated Vacci…
- 肺炎球菌ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7551.8 million by 2025, from USD 7242 million in 2019. The Pneumococ…